Ethics declarations Funding VSS is supported by a Department of Medicine Eliot Phillipson Clinician-Scientist Training Program, a Banting and Best Diabetes Centre Postdoctoral Fellowship at the University of Toronto and a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Research Award
By activating both GLP-1 and GIP receptors, tirzepatide can improve insulin sensitivity, increase feelings of fullness, and reduce food cravings
An 8-year prospective study of 3977 adults aged 55-80 years reported that persons in the group consuming the highest glycemic index diet had a 17% greater risk of getting large drusen (yellow deposits beneath the retina) in the eyes (Chiu, Milton 2007
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
In this situation, it is safer to discard it and use a new one
Decreased levels of Bacteriodetes bacteria are associated with the gut microbiota of ASD patients
